Decreto 582 de 2017: Amendments to Colombian Device Regulation

1. Key takeaways

Decreto 582 de 2017, published on April 4, 2017, is the third and most consequential amendment to Decreto 4725 de 2005. It mainly touched four areas: setting processing deadlines for INVIMA, refining the renewal and change procedures, supplementing the post-market inspection mechanism, and clarifying the rules on suspension and cancellation. Its single most influential provision is the automatic renewal for Class I/IIa established by Art. 32.

The direction of this amendment was to shift the pressure of pre-grant review backward. Combined with Article 57 of Ley 962 de 2005, under which INVIMA must carry out a follow-up control within 15 days after issuance, Colombia formed a grant-first, inspect-later pattern. The GRZAN regulatory team’s judgment is that this lowers the entry barrier while sharply raising post-market compliance demands — obtaining the certificate is the beginning, not the finish line.

2. Legal basis

3. Expert insights

#### Statutory deadlines: for the first time, companies can hold INVIMA to the clock

Before Decreto 582 de 2017, INVIMA’s processing time lacked clear statutory constraints and companies could only wait passively. After the amendment, the official review timelines are explicit: automatic registration takes 2 business days and standard registration takes 90 business days, excluding correction rounds. The GRZAN regulatory team considers this the most practically valuable change of the amendment — once deadlines are statutory, processing that exceeds them becomes something companies can formally contest, and the titular can assert its rights through the administrative procedure routes established by Ley 1437 de 2011 (CPACA). The premise is that corrections do not pause the clock: the correction reply period is 90 days (practical estimate: public sources vary between calendar days and business days), and a single unanswered correction is treated as suspension.

#### Automatic renewal drives the maintenance cost of Class I/IIa close to zero

Art. 32 provides that Class I/IIa are subject to automatic renewal. Combined with Circular Externa 100-0361-16, from October 3, 2016 the automatic renewal of Class I/IIa Registro Sanitario certificates has been processed through INVIMA’s single window, with turnaround reduced from about 30 days to about 3 business days (practical estimate) — a difference of an order of magnitude against the 90 business days of standard registration. The GRZAN judgment is that for Class I/IIa products, Colombia’s long-term maintenance cost is extremely low: companies should concentrate resources on the quality of the initial classification determination and the technical file rather than reserving redundant budget for renewals.

#### Grant-first, inspect-later pushes the compliance burden to the post-market phase

Article 57 of Ley 962 de 2005 requires INVIMA to perform a follow-up control within 15 days after issuance, which supports the grant-first logic of automatic registration. The GRZAN regulatory team cautions that under this pattern, what companies lose most easily is not the application stage but the post-market phase: serious adverse events must be reported to INVIMA within 72 hours of awareness (Resolución 4816 de 2008), periodic reports are submitted quarterly, and recalls are executed per INVIMA instructions. The existence of suspension and cancellation rules means a single serious vigilance failure can overturn all prior compliance investment.

4. Practical recommendations

1. The GRZAN regulatory team builds a deadline ledger for every application: track automatic registration at 2 business days and standard registration at 90 business days, and launch a written follow-up request the moment a deadline is exceeded.
2. The titular should designate a dedicated correction contact and an internal approval chain so that correction replies are completed within 90 days (practical estimate), avoiding suspension from a single missed correction.
3. For Class I/IIa products, use the automatic renewal of Art. 32 together with the single-window processing of Circular Externa 100-0361-16, setting the renewal turnaround expectation at about 3 business days (practical estimate).
4. Anticipate the follow-up control within 15 days after issuance under Article 57 of Ley 962 de 2005 by archiving the original technical file, label specimens and import records in advance.
5. Establish a post-market vigilance mechanism: report serious adverse events to INVIMA within 72 hours, submit quarterly periodic reports on time, and execute recalls strictly per INVIMA instructions.
6. Where suspension or cancellation risk arises, assert rights through the procedures established by Ley 1437 de 2011 (CPACA), with the local legal representative (apoderado) acting within the statutory time limits.
7. Agree in writing between the foreign manufacturer and the titular on deadlines and responsible persons for vigilance information exchange, so the information chain does not break and reporting does not lapse.

5. Verification checklist

• □ Review timeline expectations have been confirmed by pathway: automatic registration 2 business days / standard registration 90 business days
• □ An internal approval chain for correction replies exists, tracked against a 90-day reply period (practical estimate)
• □ Class I/IIa products have been confirmed as eligible for the automatic renewal of Art. 32
• □ Renewal processing has been confirmed through the single window of Circular Externa 100-0361-16, with turnaround expected at about 3 business days (practical estimate)
• □ The follow-up control within 15 days of issuance (Ley 962 de 2005 Art. 57) has been anticipated and documents archived
• □ A process for 72-hour serious adverse event reporting and quarterly periodic reporting has been established (Resolución 4816 de 2008)
• □ The procedural routes for suspension/cancellation and the local legal representative’s authority to act have been confirmed (Ley 1437 de 2011)

Regulatory information verified as of October 29, 2026

All outward-facing conclusions are based on the current regulatory texts published by the competent authorities and are verified item by item before delivery.

GRZAN provides end-to-end INVIMA registration and compliance support for manufacturers entering the Colombian market, covering timeline management, renewal and change procedures, post-market vigilance and administrative remedies. For inquiries about INVIMA registration in Colombia, contact info@grzanglobal.com.